Glycan Modifications to the Gp120 Immunogens Used in the RV144 Vaccine Trial Improve Binding to Broadly Neutralizing AntibodiesRachel C. Doran,Gwen P. Tatsuno,Sara M. O'Rourke,Bin Yu,David L. Alexander,Kathryn A. Mesa,Phillip W. BermanPLoS ONE（2018）引用 16|浏览41AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
